Hepatic Fibrosis – Therapeutic Strategies

Publisher： Karger

E-ISSN： 1421-9867|59|4|385-390

ISSN： 0012-2823

Source： Digestion, Vol.59, Iss.4, 1998-08, pp. : 385-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats

By Ueki Masaru   Koda Masahiko   Yamamoto Satoru   Matsunaga Yoshiko   Murawaki Yoshikazu  

Journal of Gastroenterology, Vol. 41, Iss. 10, 2006-10 ,pp. : 996-1004

Springer Publishing Company

Access to resources Recommend Favorite

Hepatic Fibrosis: Emerging Therapies

By  

Digestive Diseases, Vol. 33, Iss. 4, 2015-07 ,pp. : 504-507

Karger

Access to resources Recommend Favorite

Cellular Networks in Hepatic Fibrosis

By  

Digestion, Vol. 59, Iss. 4, 1998-08 ,pp. : 368-371

Karger

Access to resources Recommend Favorite

Leptin in the Field of Hepatic Fibrosis: A Pivotal or an Incidental Player?

By Bethanis Sotirios   Theocharis Stamatios  

Digestive Diseases and Sciences, Vol. 51, Iss. 10, 2006-10 ,pp. : 1685-1696

Springer Publishing Company

Access to resources Recommend Favorite

Molecular Mechanisms of Hepatic Fibrosis in Non-Alcoholic Steatohepatitis

By  

Digestive Diseases, Vol. 28, Iss. 1, 2010-05 ,pp. : 229-235

Karger

Access to resources Recommend Favorite